Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
37.16
-0.40 (-1.06%)
Nov 20, 2026, 2:04 PM EST - Market open
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $3.65 billion as of November 20, 2026. It is the 4,281st most valuable company in the world and the 1,333rd biggest in the United States. Its market cap has increased by 16.27% in one year.
Market Cap
3.65B
Enterprise Value
2.50B
1-Year Change
16.27%
Global Rank
Country Rank
#1,333 United States
Category
ChartMarket Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $3.65B, an increase of 2,468.40%. That is a compound annual growth rate of 30.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.65B | 5.45% |
| Dec 31, 2025 | 3.46B | 15.89% |
| Dec 31, 2024 | 2.99B | -0.83% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
| Nov 5, 2014 (IPO) | 142.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Definium Therapeutics | 3.99B |
| CRISPR Therapeutics AG | 3.90B |
| Tarsus Pharmaceuticals | 3.74B |
| Tango Therapeutics | 3.71B |
| SELLAS Life Sciences Group | 3.66B |
| Relay Therapeutics | 3.65B |
| AbCellera Biologics | 3.60B |
| Parabilis Medicines | 3.57B |